Anderson C H, Beattie C W
Department of Anatomy and Cell Biology, University of Illinois, Chicago 60680.
Cancer Res. 1992 Sep 15;52(18):5076-81.
Administration of the direct acting carcinogen N-methyl-N-nitrosourea (NMU) to 50-55-day-old virgin female rats on different days of the estrous cycle yields differential breast tumor biology (T. A. Ratko and C. W. Beattie, Cancer Res., 45: 3042-3047). One basis for these estrous cycle-dependent differences may be the duration of cell cycle stages of susceptible structures such as mammary terminal end buds or the quantity and duration of repair effected following adduct formation within these structures. The terminal end bud (TEB) epithelial cell cycle was characterized using pulse injections of [3H]thymidine (0.5 mCi/g body weight). On estrus, TEB epithelial cell cycle was significantly shorter (15.5 h) than on proestrus (19.9 h) and diestrus (18.8 h). The shorter duration in TEB cell cycle on estrus was likely due to a shorter TG1 (3-4 h) (P less than 0.05) since TS and TG2 did not differ between estrous cycle days. When NMU was injected 1 h after [3H]thymidine, the labeled mitotic wave within TEB of diestrus rats recovered approximately 2-3 h sooner than those given injections during proestrus (P less than 0.01), suggesting less initial damage or a slightly faster rate of DNA adduct repair. When [3H]thymidine was injected 1-5 days after the NMU, the percentage of labeled mitoses of rats given injections during diestrus and proestrus recovered to near normal 48 h after NMU, although the proportion of all cells labeled was still low compared to non-NMU-treated rats. The percentage of labeled mitoses and labeling of cells were normal 3 and 5 days after NMU. Rats receiving a carcinogenic but sublethal dose of NMU (5 mg/100 g body weight), followed by [3H]thymidine injection within 1 min, had one-half the intensity of thymidine incorporation into the terminal end bud DNA of non-NMU-treated rats. Unscheduled DNA synthesis was not demonstrable within the first 48 h following injection of NMU. The results support and extend the finding that rat mammary epithelial cell carcinogenicity of NMU is estrous cycle dependent and appears to be correlated with a differential response in the cell cycle of TEB (shorter at estrus) or delayed recovery in response to NMU (proestrus versus diestrus).
在动情周期的不同时间给50 - 55日龄的未孕雌性大鼠施用直接作用致癌物N - 甲基 - N - 亚硝基脲(NMU),会产生不同的乳腺肿瘤生物学特性(T. A. Ratko和C. W. Beattie,《癌症研究》,45: 3042 - 3047)。这些依赖动情周期的差异的一个原因可能是易感结构(如乳腺终末芽)细胞周期阶段的持续时间,或者是这些结构内加合物形成后修复的数量和持续时间。使用[3H]胸腺嘧啶核苷(0.5 mCi/g体重)脉冲注射来表征终末芽(TEB)上皮细胞周期。在发情期,TEB上皮细胞周期(15.5小时)明显短于动情前期(19.9小时)和动情间期(18.8小时)。发情期TEB细胞周期持续时间较短可能是由于TG1较短(3 - 4小时)(P < 0.05),因为TS和TG2在动情周期各天之间没有差异。当在[3H]胸腺嘧啶核苷注射后1小时注射NMU时,动情间期大鼠TEB内标记的有丝分裂波比在动情前期注射的大鼠提前约2 - 3小时恢复(P < 0.01),表明初始损伤较小或DNA加合物修复速率略快。当在NMU注射后1 - 5天注射[3H]胸腺嘧啶核苷时,动情间期和动情前期注射的大鼠标记有丝分裂的百分比在NMU注射后48小时恢复到接近正常,尽管与未用NMU处理的大鼠相比,所有标记细胞的比例仍然较低。NMU注射后3天和5天,标记有丝分裂的百分比和细胞标记正常。接受致癌但亚致死剂量NMU(5 mg/100 g体重),随后在1分钟内注射[3H]胸腺嘧啶核苷的大鼠,胸腺嘧啶核苷掺入终末芽DNA的强度是未用NMU处理大鼠的一半。在注射NMU后的前48小时内未检测到非预定DNA合成。这些结果支持并扩展了以下发现:NMU对大鼠乳腺上皮细胞的致癌性依赖于动情周期,并且似乎与TEB细胞周期的不同反应(发情期较短)或对NMU的延迟恢复(动情前期与动情间期)相关。